Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Downgrades NeuBase Therapeutics to Perform

Oppenheimer Downgrades NeuBase Therapeutics to Perform

Oppenheimer analyst Hartaj Singh downgrades NeuBase Therapeutics (NASDAQ:NBSE) from Outperform to Perform.

byBenzinga Newsdesk

October 21, 2022

1 minute read

Oppenheimer analyst Hartaj Singh downgrades NeuBase Therapeutics (NASDAQ:NBSE) from Outperform to Perform.

Why Las Vegas Sands Stock Hit A New 52-Week High Today

By Henry Khederian

January 26, 1:02 PM

Las Vegas Sands Corp. (NYSE: LVS) shares are trading higher by 5.35% to $57.97 Thursday morning despite the company reporting worse-than-expected fourth-quarter adjusted EPS and sales results.

LVS

Ethereum Tops This Major Level, Here Are Other Crypto Movers That Should Be On Your Radar Today

By Lisa Levin

October 4, 3:43 AM

Bitcoin (CRYPTO: BTC), the most valued cryptocurrency in the world, traded higher this morning, approaching the major $20,000 level.

$DOGE

Analyst Ratings

Analyst Ratings For ASML Holding

By Benzinga Insights

January 26, 5:01 PM

4 analysts have shared their evaluations of ASML Holding (NASDAQ:ASML) during the recent three months, expressing a mix…

ASML

Facebook, YouTube, Twitter May Be Impacted As Vietnam Reportedly Plans Rules To Limit News Posts On Social Media

By Navdeep Yadav

September 29, 7:57 AM

Vietnam is reportedly planning to introduce new laws to limit which social media accounts can post news-related content.

GOOG

Oppenheimer Downgrades NeuBase Therapeutics to Perform

Related Posts

Why Las Vegas Sands Stock Hit A New 52-Week High Today

Ethereum Tops This Major Level, Here Are Other Crypto Movers That Should Be On Your Radar Today

Analyst Ratings For ASML Holding

Facebook, YouTube, Twitter May Be Impacted As Vietnam Reportedly Plans Rules To Limit News Posts On Social Media